Luteolin pretreatment attenuates hepatic ischemia-reperfusion injury in mice by inhibiting inflammation, autophagy, and apoptosis via the erk/ppar α pathway

HIGHLIGHTS

• who: Yuhui Jiang and colleagues from the Department of Gastroenterology, Shanghai Tenth People`s Hospital, Tongji University School of Medicine, Shanghai, China have published the Article: Luteolin Pretreatment Attenuates Hepatic Ischemia-Reperfusion Injury in Mice by Inhibiting Inflammation, Autophagy, and Apoptosis via the ERK/PPAR u03b1 Pathway, in the Journal: PPAR Research 120 120 of 18/01/2022
• what: The aim of this study was to explore the effectiveness of luteolin in hepatic IR injury and the underlying mechanism. The study showed that luteolin can suppress autophagy and apoptosis caused by HIRI through inhibiting ERK . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.